American Journal of Transplantation · 2023 · 15 citations · 14 references
Life SciencesImmunologyPharmacotherapyAllergyPulmonologyTransplant ImmunologyImmunomodulatory Drug TherapyImmunomodulatory DrugsImmunosuppressionLung TransplantationTransplant ImmunotherapyTransplant RejectionLung Transplant PharmacotherapyLung Transplant RejectionTransplant Candidate Sensitization
Lung transplant candidates who are highly sensitized against human leucocyte antigen present an ongoing challenge with regards to finding immunologically acceptable donors. Desensitization strategies aimed at reducing preformed donor-specific antibodies have a number of limitations. Imlifidase, an IgG-degrading enzyme derived from Streptococcus pyogenes, is a novel agent that has been used to convert positive crossmatches to negative in kidney transplant candidates, allowing transplantation to occur. We present the first case of imlifidase use for antibody depletion in a highly sensitized lung transplant candidate who went on to undergo a successful bilateral lung transplant.
14
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
Stanley C. Jordan, Tomas Lorant, Jua Choi et al. · New England Journal of Medicine · 2017 · 364 citations · Full text
Medicine, Immunology, Nephrology +15
Hyperacute Rejection Following Lung Transplantation
Adaani Frost, Cory T. Jammal, Philip T. Cagle · CHEST Journal · 1996 · 115 citations
Life Sciences, Immunology, Surgery +12
Stanley C. Jordan, Christophe Legendre, Niraj M. Desai et al. · Transplantation · 2020 · 114 citations · Full text